3rd Quarter - Report

MEHLMAN CONSULTING, INC. for VALEANT PHARMACEUTICAL NORTH AMERICA LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

Corporate structure.

LobbyistCovered position, as disclosed
DAVID CASTAGNETTI —
MICHAEL COLLINS —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
CONSTANTINE HINGSON New Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole
BRUCE MEHLMAN —
MICHAEL ROBINSON —
DAVID R THOMAS —
CHARLES WOOTERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Labor Issues/Antitrust/Workplace LBR

Corporate structure.

LobbyistCovered position, as disclosed
DAVID CASTAGNETTI —
MICHAEL COLLINS —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
CONSTANTINE HINGSON New Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole
BRUCE MEHLMAN —
MICHAEL ROBINSON —
DAVID R THOMAS —
CHARLES WOOTERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Corporate structure. Treatment of international income. Reforms targeting internationally acquired companies.

LobbyistCovered position, as disclosed
DAVID CASTAGNETTI —
MICHAEL COLLINS —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
CONSTANTINE HINGSON New Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole
BRUCE MEHLMAN —
MICHAEL ROBINSON —
DAVID R THOMAS —
CHARLES WOOTERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.